查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829851

2025年正子斷層掃描（PET）放射性追蹤劑全球市場報告

Positron Emission Tomography (PET) Radiotracer Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，正子斷層掃描 (PET) 放射性示蹤劑的市場規模呈現強勁成長勢頭，從 2024 年的 23.5 億美元增至 2025 年的 25.4 億美元，複合年成長率為 8.3%。預測期內的成長歸因於感染疾病率的上升、人們認知度和可及性的提高、新型放射性示蹤劑的出現、癌症盛行率的上升以及對預防醫學的日益重視。

正子斷層掃描 (PET) 放射性示蹤劑市場預計將在未來幾年強勁成長，到 2029 年將達到 36.1 億美元，複合年成長率為 9.2%。預測期內的成長動力包括應用領域的拓展、監管部門的核准、新興市場的成長、老年人口的成長以及 PET 放射性掃描儀的普及。預測期內的主要趨勢包括微型 PET 技術的發展、與穿戴式技術的融合、治療診斷學的擴展、奈米放射性示踪劑以及用於資料安全的區塊鏈。

正子斷層掃描 (PET) 放射性追蹤劑是用於 PET 影像的放射性物質。這些放射性追蹤劑透過注射給患者，並與特定的生物標的結合，使 PET 掃描儀能夠可視化代謝活動，並診斷癌症和神經系統疾病等疾病。

PET放射性追蹤劑的主要類型包括F-18（氟脫氧葡萄糖-18）和Ga-68（纖維母細胞活化蛋白抑制劑）。 F-18（氟脫氧葡萄糖-18）放射性追蹤劑是一種放射性葡萄糖類似物，用於PET影像評估組織代謝活動，特別適用於癌症檢測。這些放射性示蹤劑應用於各種醫學領域，包括腫瘤學、心臟病學、胃腸道疾病、內分泌疾病和神經病學。它們尤其受到醫院和診斷中心等終端用戶的青睞。

2025年春季美國關稅突然上調及其引發的貿易摩擦，對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供 PET 放射性示踪劑市場統計數據，包括全球市場規模、區域佔有率、PET 放射性示踪劑市場佔有率的競爭對手、詳細的 PET 放射性示踪劑細分市場、市場趨勢和機遇，以及在 PET 放射性示踪劑行業取得成功所需的數據。本 PET 放射性追蹤劑市場研究報告全面概​​述了所有必要資訊，並深入分析了該行業的現狀和未來前景。

未來五年的預測成長率為9.2%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這一影響直接影響到美國，導致迴旋加速器生產的同位素和放射性藥物前驅物的供應鏈中斷，這些前驅物主要來自比利時和南非，並可能延遲診斷成像程序。

預計感染疾病的預期成長將在未來幾年推動正子斷層掃描 (PET) 放射性追蹤劑市場的成長。感染疾病是由致病微生物（例如細菌、病毒、真菌和寄生蟲）引起的疾病。導致這些疾病傳播的因素包括氣候變遷、都市化、全球化、抗生素抗藥性和人類行為的改變，所有這些因素都會促進病原體的傳播。 PET 放射性追蹤劑在感染疾病管理中發揮關鍵作用，它可以可視化代謝活動和炎症，協助檢測感染疾病，評估治療反應，並區分感染疾病和非感染疾病，最終改善患者的預後。例如，2024年2月，英國政府機構英國衛生安全局報告稱，2023年英格蘭的結核病病例將增加10.7%，達到4850例，而2022年為4380例。因此，感染疾病的增加正在推動PET放射性示蹤劑的需求。

PET 放射性追蹤劑市場的主要企業專注於開發先進的診斷解決方案，例如 PET 造影劑，以改善癌症檢測並改善患者預後。 PET 造影劑是用於在 PET 掃描期間可視化和測量體內生物過程的放射性物質。例如，2023 年 3 月，加拿大放射性製藥公司 IsoLogic Innovative Radiopharmaceuticals 在加拿大推出了 Illuccix，也稱為 Ga-68 Gozetotide 準備試劑盒 (PSMA-11)，作為用於檢測轉移性前列腺癌的前列腺癌成像劑。該工具對於幫助醫生識別轉移性疾病和做出明智的患者管理決策至關重要。它適用於疑似轉移且適合初始確定性治療的患者，以及因血清前列腺特異性抗原 (PSA) 水平升高而疑似復發的患者。

2023年2月，美國診斷開發公司Lantheus Holdings Inc.收購了Cerveau Technologies Inc.，收購金額未揭露。此次收購旨在透過整合Cerveau的MK-6240（一種針對腦內Tau聚集的第二代PET顯像劑），增強Lantheus Holdings的成像產品線，尤其是在阿茲海默症診斷領域。 Cerveau Technologies Inc.是一家總部位於美國的資訊和技術供應商，專注於PET放射性示踪劑。

正子斷層掃描 (PET) 放射性示蹤劑市場包括 FDG（氟脫氧葡萄糖）、f-多巴（氟多巴）、C-11甲硫胺酸、C-11甲硫胺酸、F-18 naf（氟化鈉）和 C-11 膽鹼的銷售。該市場的價值是指“出廠價”，即商品生產商或製造商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值也包括商品製造商銷售的相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球正子斷層掃描 (PET) 放射性追蹤劑：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球正子斷層掃描（PET）放射性示蹤劑市場：成長率分析
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場表現：規模與成長，2019-2024 年
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場預測：2024-2029 年及 2034 年規模與成長
  • 全球正子斷層掃描 (PET) 放射性追蹤劑：總目標市場 (TAM)

第6章 市場細分

  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場（按放射性示蹤劑類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • F-18（氟脫氧葡萄糖18）
  • Ga-68（纖維母細胞活化蛋白抑制劑）
  • 其他類型的放射性示蹤劑
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 心臟病
  • 消化器官系統
  • 內分泌
  • 神經系統疾病
  • 其他用途
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場：按最終用戶、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 其他最終用戶
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場：按 F-18（氟脫氧葡萄糖-18）細分，類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • F-18 FDG（氟脫氧葡萄糖）
  • F-18 氟乙基酪胺酸 (FET)
  • F-18 florbetapir（澱粉樣蛋白 PET 影像）
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場：按 Ga-68（纖維母細胞活化蛋白抑制劑）細分，類型，實際情況和預測，2019-2024 年、2024-2029 年、2034 年
  • Ga-68dotatate（神經內分泌腫瘤成像）
  • Ga-68 PSMA（前列腺特異性膜抗原成像）
  • Ga-68 FAPI（纖維母細胞活化蛋白抑制劑成像）
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場：細分其他放射性示蹤劑類型（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • C-11（碳11）
  • N-13（氮13）
  • O-15（氧15）
  • Rb-82（銣-82）
  • I-124（碘-124）

第7章 區域和國家分析

  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場：區域分析、預測與趨勢（2019-2024 年、2024-2029 年及 2034 年）
  • 全球正子斷層掃描 (PET) 放射性示蹤劑市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 正子斷層掃描 (PET) 放射性示蹤劑市場：競爭格局
  • 正子斷層掃描（PET）放射性示蹤劑市場：公司簡介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Philips Healthcare
  • Bracco Imaging SpA
  • Neusoft Medical Systems Co. Ltd.
  • Lantheus Holdings Inc.
  • Jubilant Pharma Limited
  • SOFIE Biosciences（SOFIE）
  • Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • Nordion Inc.
  • RefleXion Medical Inc.
  • Isologic Innovative Radiopharmaceuticals
  • ABX Advanced Biochemical Compounds GmbH
  • IBA Radiopharma Solutions SA
  • IXICO PLC
  • ImaginAb Inc.
  • Radiomedix Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年正子斷層掃描（PET）放射性追蹤劑市場：提供新機會的國家
  • 2029年正子斷層掃描（PET）放射性追蹤劑市場：細分市場帶來新機會
  • 正子斷層掃描 (PET) 放射性示蹤劑市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32170u

A positron emission tomography (PET) radiotracer is a radioactive substance used in PET imaging. This radiotracer is administered to a patient via injection, where it binds to specific biological targets, enabling the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

The primary types of PET radiotracers include F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), and others. F-18 (Fluorodeoxyglucose 18) radiotracers are radioactive glucose analogs utilized in PET imaging to evaluate metabolic activity in tissues, particularly for cancer detection. These radiotracers are applied across various medical fields, including oncology, cardiology, gastrointestinal disorders, endocrine issues, and neurology. They are used by end-users such as hospitals and diagnostic centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The positron emission tomography (PET) radiotracer market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) radiotracer market statistics, including the positron emission tomography (PET) radiotracer industry's global market size, regional shares, competitors with a positron emission tomography (PET) radiotracer market share, detailed positron emission tomography (PET) radiotracer market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) radiotracer industry. This positron emission tomography (PET) radiotracer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The positron emission tomography (pet) radiotracer market size has grown strongly in recent years. It will grow from $2.35 billion in 2024 to $2.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the increasing prevalence of infectious diseases, increasing awareness and accessibility, the emergence of novel radiotracers, the rising prevalence of cancer, and the increasing focus on preventive medicine.

The positron emission tomography (pet) radiotracer market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the expansion of applications, regulatory approvals, growth in emerging markets, growing geriatric population, and growing adoption of PET radio scanners. Major trends in the forecast period include the development of micro-pet technology, integration with wearable technology, expansion of theranostics, nano-radiotracers, and blockchain for data security.

The forecast of 9.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for cyclotron-produced isotopes and radiopharmaceutical precursors, key imports from Belgium and South Africa, potentially delaying diagnostic imaging procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in infectious diseases is projected to drive the growth of the positron emission tomography (PET) radiotracer market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites. Factors contributing to the increased prevalence of these diseases include climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which facilitate the spread of pathogens. PET radiotracers play a crucial role in managing infectious diseases by visualizing metabolic activity and inflammation, which aids in the detection of infections, assessment of treatment responses, and differentiation between infectious and non-infectious conditions, ultimately leading to improved patient outcomes. For example, in February 2024, a report from the UK Health Security Agency, a government agency in the UK, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Hence, the growing prevalence of infectious diseases is driving demand for the PET radiotracer market.

Leading companies in the PET radiotracer market are concentrating on developing advanced diagnostic solutions, such as PET imaging agents that improve cancer detection and enhance patient outcomes. A PET imaging agent is a radioactive substance utilized to visualize and measure biological processes in the body during PET scans. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canadian radiopharmaceutical firm, launched Illuccix, also known as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada as a prostate cancer imaging agent aimed at detecting metastatic prostate cancer. This tool is crucial for physicians in identifying metastatic disease and making informed patient management decisions. It is indicated for patients suspected of metastasis who are candidates for initial definitive therapy, as well as for those with suspected recurrence indicated by elevated serum prostate-specific antigen (PSA) levels.

In February 2023, Lantheus Holdings Inc., a U.S.-based developer of diagnostic products, acquired Cerveau Technologies for an undisclosed sum. This acquisition is intended to enhance Lantheus Holdings' imaging pipeline, particularly for Alzheimer's disease diagnostics, by integrating Cerveau's MK-6240, a second-generation PET imaging agent that targets tau tangles in the brain. Cerveau Technologies Inc. is a U.S.-based provider of information and technology specializing in PET radiotracers.

Major companies operating in the positron emission tomography (PET) radiotracer market are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) radiotracer marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) radiotracer market consists of sales of FDG (fluorodeoxyglucose), f-dopa (fluorodopa), C-11 methionine, C-11 methionine, F-18 naf (sodium fluoride), and C-11 choline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Radiotracer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on positron emission tomography (pet) radiotracer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (pet) radiotracer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The positron emission tomography (pet) radiotracer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18); Ga-68 (Fibroblast Activation Protein Inhibitor); Other Radiotracer Types
  • 2) By Application: Cancer; Heart Disease; Gastrointestinal; Endocrine; Neurological Disorders; Other Applications
  • 3) By End-User: Hospitals; Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose); F-18 Fluoroethyltyrosine (FET); F-18 Florbetapir (Amyloid PET Imaging)
  • 2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging); Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging); Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
  • 3) By Other Radiotracer Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Rb-82 (Rubidium-82); I-124 (Iodine-124)
  • Companies Mentioned: Cardinal Health Inc.; AstraZeneca PLC; Eli Lilly and Company; Siemens Healthineers AG; GE Healthcare Technologies Inc.; Philips Healthcare; Bracco Imaging S.p.A.; Neusoft Medical Systems Co Ltd.; Lantheus Holdings Inc.; Jubilant Pharma Limited; SOFIE Biosciences (SOFIE); Yantai Dongcheng Pharmaceutical Group Co. Ltd.; Nordion Inc.; RefleXion Medical Inc.; Isologic Innovative Radiopharmaceuticals; ABX Advanced Biochemical Compounds GmbH; IBA Radiopharma Solutions S.A.; IXICO PLC; ImaginAb Inc.; Radiomedix Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Positron Emission Tomography (PET) Radiotracer Market Characteristics

3. Positron Emission Tomography (PET) Radiotracer Market Trends And Strategies

4. Positron Emission Tomography (PET) Radiotracer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Positron Emission Tomography (PET) Radiotracer Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Positron Emission Tomography (PET) Radiotracer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Positron Emission Tomography (PET) Radiotracer Market Growth Rate Analysis
  • 5.4. Global Positron Emission Tomography (PET) Radiotracer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Positron Emission Tomography (PET) Radiotracer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Positron Emission Tomography (PET) Radiotracer Total Addressable Market (TAM)

6. Positron Emission Tomography (PET) Radiotracer Market Segmentation

  • 6.1. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • F-18 (Fluorodeoxyglucose 18)
  • Ga-68 (Fibroblast Activation Protein Inhibitor)
  • Other Radiotracer Types
  • 6.2. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Heart Disease
  • Gastrointestinal
  • Endocrine
  • Neurological Disorders
  • Other Applications
  • 6.3. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Other End-Users
  • 6.4. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of F-18 (Fluorodeoxyglucose 18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • F-18 FDG (Fluorodeoxyglucose)
  • F-18 Fluoroethyltyrosine (FET)
  • F-18 Florbetapir (Amyloid PET Imaging)
  • 6.5. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Ga-68 (Fibroblast Activation Protein Inhibitor), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ga-68 Dotatate (Neuroendocrine Tumor Imaging)
  • Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging)
  • Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
  • 6.6. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Other Radiotracer Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • C-11 (Carbon-11)
  • N-13 (Nitrogen-13)
  • O-15 (Oxygen-15)
  • Rb-82 (Rubidium-82)
  • I-124 (Iodine-124)

7. Positron Emission Tomography (PET) Radiotracer Market Regional And Country Analysis

  • 7.1. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market

  • 8.1. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Positron Emission Tomography (PET) Radiotracer Market

  • 9.1. China Positron Emission Tomography (PET) Radiotracer Market Overview
  • 9.2. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Positron Emission Tomography (PET) Radiotracer Market

  • 10.1. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Positron Emission Tomography (PET) Radiotracer Market

  • 11.1. Japan Positron Emission Tomography (PET) Radiotracer Market Overview
  • 11.2. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Positron Emission Tomography (PET) Radiotracer Market

  • 12.1. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Positron Emission Tomography (PET) Radiotracer Market

  • 13.1. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Positron Emission Tomography (PET) Radiotracer Market

  • 14.1. South Korea Positron Emission Tomography (PET) Radiotracer Market Overview
  • 14.2. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Positron Emission Tomography (PET) Radiotracer Market

  • 15.1. Western Europe Positron Emission Tomography (PET) Radiotracer Market Overview
  • 15.2. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Positron Emission Tomography (PET) Radiotracer Market

  • 16.1. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Positron Emission Tomography (PET) Radiotracer Market

  • 17.1. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Positron Emission Tomography (PET) Radiotracer Market

  • 18.1. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Positron Emission Tomography (PET) Radiotracer Market

  • 19.1. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Positron Emission Tomography (PET) Radiotracer Market

  • 20.1. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market

  • 21.1. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market Overview
  • 21.2. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Positron Emission Tomography (PET) Radiotracer Market

  • 22.1. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Positron Emission Tomography (PET) Radiotracer Market

  • 23.1. North America Positron Emission Tomography (PET) Radiotracer Market Overview
  • 23.2. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Positron Emission Tomography (PET) Radiotracer Market

  • 24.1. USA Positron Emission Tomography (PET) Radiotracer Market Overview
  • 24.2. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Positron Emission Tomography (PET) Radiotracer Market

  • 25.1. Canada Positron Emission Tomography (PET) Radiotracer Market Overview
  • 25.2. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Positron Emission Tomography (PET) Radiotracer Market

  • 26.1. South America Positron Emission Tomography (PET) Radiotracer Market Overview
  • 26.2. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Positron Emission Tomography (PET) Radiotracer Market

  • 27.1. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Positron Emission Tomography (PET) Radiotracer Market

  • 28.1. Middle East Positron Emission Tomography (PET) Radiotracer Market Overview
  • 28.2. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Positron Emission Tomography (PET) Radiotracer Market

  • 29.1. Africa Positron Emission Tomography (PET) Radiotracer Market Overview
  • 29.2. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Company Profiles

  • 30.1. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape
  • 30.2. Positron Emission Tomography (PET) Radiotracer Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Positron Emission Tomography (PET) Radiotracer Market Other Major And Innovative Companies

  • 31.1. Philips Healthcare
  • 31.2. Bracco Imaging S.p.A.
  • 31.3. Neusoft Medical Systems Co. Ltd.
  • 31.4. Lantheus Holdings Inc.
  • 31.5. Jubilant Pharma Limited
  • 31.6. SOFIE Biosciences (SOFIE)
  • 31.7. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • 31.8. Nordion Inc.
  • 31.9. RefleXion Medical Inc.
  • 31.10. Isologic Innovative Radiopharmaceuticals
  • 31.11. ABX Advanced Biochemical Compounds GmbH
  • 31.12. IBA Radiopharma Solutions S.A.
  • 31.13. IXICO PLC
  • 31.14. ImaginAb Inc.
  • 31.15. Radiomedix Inc.

32. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

34. Recent Developments In The Positron Emission Tomography (PET) Radiotracer Market

35. Positron Emission Tomography (PET) Radiotracer Market High Potential Countries, Segments and Strategies

  • 35.1 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer